Creo Medical Group Plc
(LSE) CREO
Creo Medical Group Plc Financials at a Glance
Market Cap
$4.85B
Revenue (TTM)
$48.20M
Net Income (TTM)
$17.10M
EPS (TTM)
$0.00
P/E Ratio
-1.96
Dividend
$0.00
Beta (Volatility)
-0.02 (Low)
Dividend
$0.00
Beta (Volatility)
-0.02 (Low)
Price
$11.71
Volume
750,707
Open
$11.00
Price
$11.71
Volume
750,707
Open
$11.00
Previous Close
$11.71
Daily Range
$11.00 - $12.00
52-Week Range
$9.50 - $18.50
Dividend
$0.00
Beta (Volatility)
-0.02 (Low)
Price
$11.71
Volume
750,707
Open
$11.00
Previous Close
$11.71
Daily Range
$11.00 - $12.00
52-Week Range
$9.50 - $18.50
CREO News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Creo Medical Group Plc
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
141
CEO
Craig Jonathan Gulliford
Website
www.creomedical.comHeadquarters
Chepstow, NP16 5UH, GB
CREO Financials
Key Financial Metrics (TTM)
Gross Margin
45%
Operating Margin
-5%
Net Income Margin
8%
Return on Equity
0%
Return on Capital
-16%
Return on Assets
25%
Earnings Yield
-51.02%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$4.85B
Shares Outstanding
412.47M
Volume
750.71K
Short Interest
0.00%
Avg. Volume
880.38K
Financials (TTM)
Gross Profit
$1.90M
Operating Income
$28.80M
EBITDA
$26.10M
Operating Cash Flow
$22.20M
Capital Expenditure
$400.00K
Free Cash Flow
$22.60M
Cash & ST Invst.
$8.70M
Total Debt
$4.40M
Creo Medical Group Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.20M
-83.7%
Gross Profit
$1.00M
-79.6%
Gross Margin
45.45%
N/A
Market Cap
$4.85B
N/A
Market Cap/Employee
$17.43M
N/A
Employees
278
N/A
Net Income
$16.90M
+225.2%
EBITDA
$9.50M
+27.5%
Quarterly Fundamentals
Net Cash
$16.30M
-5.8%
Accounts Receivable
$3.40M
-76.7%
Inventory
$3.20M
-60.0%
Long Term Debt
$1.90M
-66.1%
Short Term Debt
$2.30M
-36.1%
Return on Assets
24.56%
N/A
Return on Invested Capital
-15.92%
N/A
Free Cash Flow
$15.30M
+199.4%
Operating Cash Flow
$15.30M
+202.7%